<i>Jak2V617F</i> Reversible Activation Shows an Essential Requirement for Jak2V617F in Myeloproliferative Neoplasms (MPNs)Andrew Dunbar, Ross L. Levine, Won Jun Kim et al.|Blood|2022Cited by 4
Modeling clonal evolution and oncogenic dependency in vivo in the context of hematopoietic transformationRobert L. Bowman, Ross L. Levine, Andrew Dunbar et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 2
Erythroid and Megakaryocytic Differentiation Program in <i>JAK2</i>-Mutated Acute Myeloid Leukemia with or without Antecedent Myeloproliferative NeoplasmYing Liu, Wenbin Xiao, Shenon Sethi et al.|Blood|2022Cited by 0